Dunne, Jaclyn
Griner, Jake
Romeo, Martin
Macdonald, Jade
Krieg, Carsten
Lim, Mark
Yagnik, Gargey
Rothschild, Kenneth J.
Drake, Richard R.
Mehta, Anand S.
Angel, Peggi M.
Funding for this research was provided by:
Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)
National Institute of General Medical Sciences (5T32GM132055, P20GM103542)
National Institutes of Health (5R01AG067510-03, R01CA253460, R44AG078097, R44CA236097, R44MH132196, S10 0D030212, S10 OD010731, S10 OD025126)
Article History
Received: 4 August 2023
Revised: 7 September 2023
Accepted: 18 September 2023
First Online: 16 October 2023
Declarations
:
: Tissues from MUSC’s Biorepository & Tissue Analysis shared resource were approved for use for this study by MUSC IRB board as exemption #4.
: M.J.L., G.Y., and K.J.R. are current employees of AmberGen, Inc., 44 Manning Road, Billerica, MA 01821, USA. PMA and RRD are board members of N-zyme Scientifics, LLC, 3805 Old Easton Road, Doylestown, PA 18902, USA. ASM is founder and board member of N-zyme Scientifics, LLC, 3805 Old Easton Road, Doylestown, PA 18902, USA. All other authors do not have any conflicts of interest to disclose.